JPS5690097A - Novel thinated polypeptide compound*its manufacture and its use - Google Patents

Novel thinated polypeptide compound*its manufacture and its use

Info

Publication number
JPS5690097A
JPS5690097A JP16683380A JP16683380A JPS5690097A JP S5690097 A JPS5690097 A JP S5690097A JP 16683380 A JP16683380 A JP 16683380A JP 16683380 A JP16683380 A JP 16683380A JP S5690097 A JPS5690097 A JP S5690097A
Authority
JP
Japan
Prior art keywords
thinated
novel
manufacture
polypeptide compound
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP16683380A
Other languages
English (en)
Japanese (ja)
Inventor
Bijinii Berunaaru
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Publication of JPS5690097A publication Critical patent/JPS5690097A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K19/00Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/385Haptens or antigens, bound to carriers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/6415Toxins or lectins, e.g. clostridial toxins or Pseudomonas exotoxins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • C07D213/71Sulfur atoms to which a second hetero atom is attached
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/34Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/60Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031Proteins
    • A61K2039/6037Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP16683380A 1979-11-28 1980-11-28 Novel thinated polypeptide compound*its manufacture and its use Pending JPS5690097A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7929289A FR2470773B1 (US07829113-20101109-C00009.png) 1979-11-28 1979-11-28

Publications (1)

Publication Number Publication Date
JPS5690097A true JPS5690097A (en) 1981-07-21

Family

ID=9232177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16683380A Pending JPS5690097A (en) 1979-11-28 1980-11-28 Novel thinated polypeptide compound*its manufacture and its use

Country Status (5)

Country Link
EP (2) EP0030496B1 (US07829113-20101109-C00009.png)
JP (1) JPS5690097A (US07829113-20101109-C00009.png)
CA (1) CA1152493A (US07829113-20101109-C00009.png)
ES (2) ES8202831A1 (US07829113-20101109-C00009.png)
FR (1) FR2470773B1 (US07829113-20101109-C00009.png)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2498192A2 (fr) * 1981-01-22 1982-07-23 Pasteur Institut Nouveau compose polypeptidique thiole provenant d'un fragment de la toxine tetanique, son procede d'obtention et ses applications
SE8102193L (sv) * 1981-04-06 1982-10-07 Pharmacia Ab Terapeutiskt aktiv organisk forening och dess anvendning
GB8334499D0 (en) * 1983-12-24 1984-02-01 Beecham Group Plc Derivatives
JPH06507639A (ja) * 1991-05-03 1994-09-01 ザ ロックフェラー ユニバーシティ セレクチンとb百日咳毒素の間のアミノ酸シーケンスの相同性−それから誘導されるペプチド、それに対する抗体、薬剤組成物
US7923216B2 (en) 1997-08-14 2011-04-12 Institut Pasteur In vivo modulation of neuronal transport
ES2281135T3 (es) 1997-08-14 2007-09-16 Institut Pasteur Proteinas hibridas de un toxoide tetanico que migran de forma retrograda y transinaptica al snc.
US7923015B2 (en) 1997-08-14 2011-04-12 Institut Pasteur Methods for direct visualization of active synapses

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3171831A (en) * 1961-02-14 1965-03-02 Schwarz Biores Inc Thiolation of proteins by reaction with homocysteine thiolactone in the presence of tertiary amine
DE1617880A1 (de) * 1966-10-06 1971-07-22 Karl Dr Med Theurer Verfahren zur Gewinnung von organotropen,bioaktiven Wirkstoffen,insbesondere von Arzneimitteln
FR2270891A2 (en) * 1974-05-15 1975-12-12 Anvar Vaccines by glutaraldehyde detoxification - especially multivalent vaccines e.g. against tetanus and diphtheria
IN140168B (US07829113-20101109-C00009.png) * 1974-10-14 1976-09-25 All India Inst Med
JPS5272284A (en) * 1975-12-12 1977-06-16 Dainippon Pharmaceutical Co Enzymeeimmunoassay reagent
JPS5341420A (en) * 1976-09-29 1978-04-14 Mochida Pharm Co Ltd Immunochemically measuring methoa of hapten
SE427505B (sv) * 1977-03-04 1983-04-11 Pharmacia Diagnostics Ab Reagens till anvendning vid immunkemiska bestemningsmetoder
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine

Also Published As

Publication number Publication date
EP0065320B1 (fr) 1985-04-03
EP0030496B1 (fr) 1983-07-13
FR2470773A1 (US07829113-20101109-C00009.png) 1981-06-12
ES497182A0 (es) 1982-03-01
FR2470773B1 (US07829113-20101109-C00009.png) 1983-01-28
ES8202831A1 (es) 1982-03-01
ES507625A0 (es) 1983-10-16
EP0065320A1 (fr) 1982-11-24
ES8400460A1 (es) 1983-10-16
CA1152493A (en) 1983-08-23
EP0030496A1 (fr) 1981-06-17

Similar Documents

Publication Publication Date Title
JPS5695331A (en) Ferroofluid and its manufacture
JPS55100368A (en) Nnbenzylimidazole and its manufacture and use
JPS5615271A (en) Novel 11aryll44arylsulfonyll33gammaa aminopropoxyy1hhpyrazole compound and its manufacture
JPS5612370A (en) Substituted 33aryllpyrazole and 33aryllisoxazole and manufacture thereof
JPS5632427A (en) Novel 44fluoroo33phenoxyybenzaldehydeacetal* its manufacture* novel intermediate therefor and its manufacture
JPS55154979A (en) Novel 33vinylcephalosporin and its manufacture
JPS5690086A (en) 11piperidinesulfonylurea and its manufacture
JPS5651457A (en) Antitumoral compound and its manufacture
JPS54151973A (en) Novel compound*its manufacture and its compound
JPS5690097A (en) Novel thinated polypeptide compound*its manufacture and its use
JPS5626862A (en) Novel substituted phenylacetylguanidine and its manufacture
JPS5690094A (en) Hydantoinylsilane and its manufacture
JPS55108871A (en) Novel norrtropane derivative*its manufacture and use
JPS55120627A (en) Novel complex and its manufacture
JPS54122292A (en) Novel betaalactam*its manufacture and use
JPS5634655A (en) 33methyllcyclohexadecc33enee11one* its manufacture and use
JPS55124768A (en) Phenylmorphanes*its intermediate and its manufacture
JPS5688861A (en) Construction and its manufacture
JPS55151571A (en) Novel 22isopropylaminoo55halogenopyrimidine and its manufacture
JPS5634656A (en) Cyclopentadecc88enee11one* its manufacture and its use
JPS55157575A (en) Polyhaloquinoxalinesulfonate* its manufacture and its application
JPS5616441A (en) 44fluoroo33bromoobenzoylfluoride and manufacture thereof
JPS55130950A (en) Betaaalkoxyyacrylonitrile*33aminooacryonitrile and 22cyanoovinylester manufacture
JPS54145624A (en) Novel compound and its manufacture
JPS5616435A (en) 33methylaldehyde* its manufacture and use